They treat cerebrovascular infarction with stem cells

• April 19, 2024

For the first time, Scottish researchers treated a patient with a pioneering clinical test of their type that will allow to know if the therapy of mother cells could help patients suffering from cerebrovascular infarction, publishes the Yahoo News news portal,

The biotechnology company ReNeuron Group Inc. He performed this first test in the world to use neuronal stem cells in therapy for patients with cerebro-vascular infarcts , and although there is optimism, the experts still warn that the results should be cautiously awaited.

The first patient had a successful surgery and has been discharged from the hospital, according to the research leader, Keith Muir of the Glasgow's Southern General Hospital and will be monitored for two years. Long-term check-ups will also be necessary to determine if the treatment It is successful or not.

"Cerebrovascular infarction is a common but serious condition that leaves a large number of people with a significant disability . In this test we are looking to establish safety and viability in the implantation of stem cells, which require a constant and careful review of the patients who are part of the test "indicated Professor Muir of the University of the Institute of Neuroscience and Psychology of Glasgow for the science portal www.physorg.com